author-photo

Gurkamal Chatta

Roswell Park Cancer Institute

21

Papers

150

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Glucocorticoid signaling delays castration-induced regression in murine models of prostate cancer

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.

2018 Nature Communications
Show All
- Source
- Cite
- Save
Citations (64)
TRITON2: An international, multicenter, open-label, phase II study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice

2017 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (13)
Expression of NY-ESO-1 cancer testis antigen in prostate cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Trastuzumab (T), paclitaxel (P), carboplatin (C), and gemcitabine (G) in advanced HER2-positive urothelial carcinoma: Results of a multi-center phase II NCI trial

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (35)
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02

2004 Urologic Oncology-seminars and Original Investigations
- Gurkamal Chatta
Show All
- Source
- Cite
- Save
Citations (0)
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer

2004 Urologic Oncology-seminars and Original Investigations
- Gurkamal Chatta
Show All
- Source
- Cite
- Save
Citations (0)
Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer

2004 Urologic Oncology-seminars and Original Investigations
- Gurkamal Chatta
Show All
- Source
- Cite
- Save
Citations (0)
Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure

2004 Urologic Oncology-seminars and Original Investigations
- Gurkamal Chatta
Show All
- Source
- Cite
- Save
Citations (0)